Delivery of nanovaccine towards lymphoid organs: recent strategies in enhancing cancer immunotherapy
Abstract With the in-depth exploration on cancer therapeutic nanovaccines, increasing evidence shows that the poor delivery of nanovaccines to lymphoid organs has become the culprit limiting the rapid induction of anti-tumor immune response. Unlike the conventional prophylactic vaccines that mainly...
Saved in:
Main Authors: | Ting Cai, Huina Liu, Shun Zhang, Jing Hu, Lingxiao Zhang |
---|---|
Format: | article |
Language: | EN |
Published: |
BMC
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/c8efa55ab0ae4d62b5de991db51d14d5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recent developments in mesoporous polydopamine-derived nanoplatforms for cancer theranostics
by: Menglu Zhu, et al.
Published: (2021) -
Hybrid membrane-coated nanosuspensions for multi-modal anti-glioma therapy via drug and antigen delivery
by: Wenyan Hao, et al.
Published: (2021) -
Correction to: Co-delivery of nanoparticle and molecular drug by hollow mesoporous organosilica for tumor-activated and photothermal-augmented chemotherapy of breast cancer
by: Haixian Zhang, et al.
Published: (2021) -
Multifaceted glycoadjuvant@AuNPs inhibits tumor metastasis through promoting T cell activation and remodeling tumor microenvironment
by: Xiaojing Xu, et al.
Published: (2021) -
Reshaping the Inflammatory Environment in Rheumatoid Arthritis Joints by Targeting Delivery of Berberine with Platelet‐Derived Extracellular Vesicles
by: Qingle Ma, et al.
Published: (2021)